Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool

Myasthenia gravis (MG) is an immune disorder that causes muscle weakness with an increasing prevalence, particularly among the elderly in Japan. Glucocorticoid treatment for MG is problematic for bone health because of reduced bone density and increased fracture risk. The fracture risk assessment tool (FRAX ®) can estimate fracture risk, but its applicability in patients with MG remains uncertain.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Source Type: research